Tafluprost: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tafluprost. Educational only — not medical advice.
Labeled uses
ZIOPTAN® (tafluprost ophthalmic solution) 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Source: FDA labeling via NIH DailyMed (set a3173c26…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.